0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Microneedles for Trans & Intradermal Drug Delivery Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-6C10113
Home | Market Reports | Health| Medical Devices & Equipment
Global Microneedles for Trans Intradermal Drug Delivery Market Insights Forecast to 2028
BUY CHAPTERS

Global Microneedles for Trans & Intradermal Drug Delivery Market Research Report 2025

Code: QYRE-Auto-6C10113
Report
January 2025
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Microneedles for Trans & Intradermal Drug Delivery Market

The global market for Microneedles for Trans & Intradermal Drug Delivery was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Microneedles for Trans & Intradermal Drug Delivery is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Microneedles for Trans & Intradermal Drug Delivery is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Microneedles for Trans & Intradermal Drug Delivery include Becton Dickinson, Nanopass Technologies, Radius Health, Clearside Biomedical, Dr. Prausnitz Group, Zosano Pharma, Corium International, Circassia, Valeritas, Inc., BD Medical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Microneedles for Trans & Intradermal Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microneedles for Trans & Intradermal Drug Delivery.
The Microneedles for Trans & Intradermal Drug Delivery market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Microneedles for Trans & Intradermal Drug Delivery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Microneedles for Trans & Intradermal Drug Delivery manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Microneedles for Trans & Intradermal Drug Delivery Market Report

Report Metric Details
Report Name Microneedles for Trans & Intradermal Drug Delivery Market
Segment by Type
Segment by Application
  • Drugs
  • Vaccines
  • Proteins
  • Peptides
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Becton Dickinson, Nanopass Technologies, Radius Health, Clearside Biomedical, Dr. Prausnitz Group, Zosano Pharma, Corium International, Circassia, Valeritas, Inc., BD Medical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Microneedles for Trans & Intradermal Drug Delivery manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Microneedles for Trans & Intradermal Drug Delivery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Microneedles for Trans & Intradermal Drug Delivery Market report?

Ans: The main players in the Microneedles for Trans & Intradermal Drug Delivery Market are Becton Dickinson, Nanopass Technologies, Radius Health, Clearside Biomedical, Dr. Prausnitz Group, Zosano Pharma, Corium International, Circassia, Valeritas, Inc., BD Medical

What are the Application segmentation covered in the Microneedles for Trans & Intradermal Drug Delivery Market report?

Ans: The Applications covered in the Microneedles for Trans & Intradermal Drug Delivery Market report are Drugs, Vaccines, Proteins, Peptides, Others

What are the Type segmentation covered in the Microneedles for Trans & Intradermal Drug Delivery Market report?

Ans: The Types covered in the Microneedles for Trans & Intradermal Drug Delivery Market report are Solid Microneedles, Hollow Microneedles, Dissolvable Microneedles

Recommended Reports

Microneedle Technologies

Microneedle Drug Delivery

Transdermal Delivery Solutions

1 Microneedles for Trans & Intradermal Drug Delivery Market Overview
1.1 Product Definition
1.2 Microneedles for Trans & Intradermal Drug Delivery by Type
1.2.1 Global Microneedles for Trans & Intradermal Drug Delivery Market Value Comparison by Type (2024 VS 2031)
1.2.2 Solid Microneedles
1.2.3 Hollow Microneedles
1.2.4 Dissolvable Microneedles
1.3 Microneedles for Trans & Intradermal Drug Delivery by Application
1.3.1 Global Microneedles for Trans & Intradermal Drug Delivery Market Value by Application (2024 VS 2031)
1.3.2 Drugs
1.3.3 Vaccines
1.3.4 Proteins
1.3.5 Peptides
1.3.6 Others
1.4 Global Microneedles for Trans & Intradermal Drug Delivery Market Size Estimates and Forecasts
1.4.1 Global Microneedles for Trans & Intradermal Drug Delivery Revenue 2020-2031
1.4.2 Global Microneedles for Trans & Intradermal Drug Delivery Sales 2020-2031
1.4.3 Global Microneedles for Trans & Intradermal Drug Delivery Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Microneedles for Trans & Intradermal Drug Delivery Market Competition by Manufacturers
2.1 Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Manufacturers (2020-2025)
2.2 Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Microneedles for Trans & Intradermal Drug Delivery Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Microneedles for Trans & Intradermal Drug Delivery, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Microneedles for Trans & Intradermal Drug Delivery, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Microneedles for Trans & Intradermal Drug Delivery, Product Type & Application
2.7 Global Key Manufacturers of Microneedles for Trans & Intradermal Drug Delivery, Date of Enter into This Industry
2.8 Global Microneedles for Trans & Intradermal Drug Delivery Market Competitive Situation and Trends
2.8.1 Global Microneedles for Trans & Intradermal Drug Delivery Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Microneedles for Trans & Intradermal Drug Delivery Players Market Share by Revenue
2.8.3 Global Microneedles for Trans & Intradermal Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Microneedles for Trans & Intradermal Drug Delivery Market Scenario by Region
3.1 Global Microneedles for Trans & Intradermal Drug Delivery Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Microneedles for Trans & Intradermal Drug Delivery Sales by Region: 2020-2031
3.2.1 Global Microneedles for Trans & Intradermal Drug Delivery Sales by Region: 2020-2025
3.2.2 Global Microneedles for Trans & Intradermal Drug Delivery Sales by Region: 2026-2031
3.3 Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Region: 2020-2031
3.3.1 Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Region: 2020-2025
3.3.2 Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Region: 2026-2031
3.4 North America Microneedles for Trans & Intradermal Drug Delivery Market Facts & Figures by Country
3.4.1 North America Microneedles for Trans & Intradermal Drug Delivery Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2020-2031)
3.4.3 North America Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Microneedles for Trans & Intradermal Drug Delivery Market Facts & Figures by Country
3.5.1 Europe Microneedles for Trans & Intradermal Drug Delivery Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2020-2031)
3.5.3 Europe Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Market Facts & Figures by Region
3.6.1 Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Sales by Region (2020-2031)
3.6.3 Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Microneedles for Trans & Intradermal Drug Delivery Market Facts & Figures by Country
3.7.1 Latin America Microneedles for Trans & Intradermal Drug Delivery Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2020-2031)
3.7.3 Latin America Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Market Facts & Figures by Country
3.8.1 Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2020-2031)
3.8.3 Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2020-2031)
4.1.1 Global Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2020-2025)
4.1.2 Global Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2026-2031)
4.1.3 Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Type (2020-2031)
4.2 Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Type (2020-2031)
4.2.1 Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Type (2020-2025)
4.2.2 Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Type (2026-2031)
4.2.3 Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Type (2020-2031)
4.3 Global Microneedles for Trans & Intradermal Drug Delivery Price by Type (2020-2031)
5 Segment by Application
5.1 Global Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2020-2031)
5.1.1 Global Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2020-2025)
5.1.2 Global Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2026-2031)
5.1.3 Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Application (2020-2031)
5.2 Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Application (2020-2031)
5.2.1 Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Application (2020-2025)
5.2.2 Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Application (2026-2031)
5.2.3 Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Application (2020-2031)
5.3 Global Microneedles for Trans & Intradermal Drug Delivery Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Becton Dickinson
6.1.1 Becton Dickinson Company Information
6.1.2 Becton Dickinson Description and Business Overview
6.1.3 Becton Dickinson Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Becton Dickinson Microneedles for Trans & Intradermal Drug Delivery Product Portfolio
6.1.5 Becton Dickinson Recent Developments/Updates
6.2 Nanopass Technologies
6.2.1 Nanopass Technologies Company Information
6.2.2 Nanopass Technologies Description and Business Overview
6.2.3 Nanopass Technologies Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Nanopass Technologies Microneedles for Trans & Intradermal Drug Delivery Product Portfolio
6.2.5 Nanopass Technologies Recent Developments/Updates
6.3 Radius Health
6.3.1 Radius Health Company Information
6.3.2 Radius Health Description and Business Overview
6.3.3 Radius Health Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Radius Health Microneedles for Trans & Intradermal Drug Delivery Product Portfolio
6.3.5 Radius Health Recent Developments/Updates
6.4 Clearside Biomedical
6.4.1 Clearside Biomedical Company Information
6.4.2 Clearside Biomedical Description and Business Overview
6.4.3 Clearside Biomedical Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Clearside Biomedical Microneedles for Trans & Intradermal Drug Delivery Product Portfolio
6.4.5 Clearside Biomedical Recent Developments/Updates
6.5 Dr. Prausnitz Group
6.5.1 Dr. Prausnitz Group Company Information
6.5.2 Dr. Prausnitz Group Description and Business Overview
6.5.3 Dr. Prausnitz Group Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Dr. Prausnitz Group Microneedles for Trans & Intradermal Drug Delivery Product Portfolio
6.5.5 Dr. Prausnitz Group Recent Developments/Updates
6.6 Zosano Pharma
6.6.1 Zosano Pharma Company Information
6.6.2 Zosano Pharma Description and Business Overview
6.6.3 Zosano Pharma Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Zosano Pharma Microneedles for Trans & Intradermal Drug Delivery Product Portfolio
6.6.5 Zosano Pharma Recent Developments/Updates
6.7 Corium International
6.7.1 Corium International Company Information
6.7.2 Corium International Description and Business Overview
6.7.3 Corium International Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Corium International Microneedles for Trans & Intradermal Drug Delivery Product Portfolio
6.7.5 Corium International Recent Developments/Updates
6.8 Circassia
6.8.1 Circassia Company Information
6.8.2 Circassia Description and Business Overview
6.8.3 Circassia Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Circassia Microneedles for Trans & Intradermal Drug Delivery Product Portfolio
6.8.5 Circassia Recent Developments/Updates
6.9 Valeritas, Inc.
6.9.1 Valeritas, Inc. Company Information
6.9.2 Valeritas, Inc. Description and Business Overview
6.9.3 Valeritas, Inc. Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Valeritas, Inc. Microneedles for Trans & Intradermal Drug Delivery Product Portfolio
6.9.5 Valeritas, Inc. Recent Developments/Updates
6.10 BD Medical
6.10.1 BD Medical Company Information
6.10.2 BD Medical Description and Business Overview
6.10.3 BD Medical Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.10.4 BD Medical Microneedles for Trans & Intradermal Drug Delivery Product Portfolio
6.10.5 BD Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Microneedles for Trans & Intradermal Drug Delivery Industry Chain Analysis
7.2 Microneedles for Trans & Intradermal Drug Delivery Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Microneedles for Trans & Intradermal Drug Delivery Production Mode & Process Analysis
7.4 Microneedles for Trans & Intradermal Drug Delivery Sales and Marketing
7.4.1 Microneedles for Trans & Intradermal Drug Delivery Sales Channels
7.4.2 Microneedles for Trans & Intradermal Drug Delivery Distributors
7.5 Microneedles for Trans & Intradermal Drug Delivery Customer Analysis
8 Microneedles for Trans & Intradermal Drug Delivery Market Dynamics
8.1 Microneedles for Trans & Intradermal Drug Delivery Industry Trends
8.2 Microneedles for Trans & Intradermal Drug Delivery Market Drivers
8.3 Microneedles for Trans & Intradermal Drug Delivery Market Challenges
8.4 Microneedles for Trans & Intradermal Drug Delivery Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Microneedles for Trans & Intradermal Drug Delivery Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Microneedles for Trans & Intradermal Drug Delivery Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Microneedles for Trans & Intradermal Drug Delivery Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Microneedles for Trans & Intradermal Drug Delivery Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Microneedles for Trans & Intradermal Drug Delivery Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Microneedles for Trans & Intradermal Drug Delivery Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Microneedles for Trans & Intradermal Drug Delivery Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Microneedles for Trans & Intradermal Drug Delivery, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Microneedles for Trans & Intradermal Drug Delivery, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Microneedles for Trans & Intradermal Drug Delivery, Product Type & Application
 Table 12. Global Key Manufacturers of Microneedles for Trans & Intradermal Drug Delivery, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Microneedles for Trans & Intradermal Drug Delivery by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microneedles for Trans & Intradermal Drug Delivery as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Microneedles for Trans & Intradermal Drug Delivery Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Microneedles for Trans & Intradermal Drug Delivery Sales by Region (2020-2025) & (K Units)
 Table 18. Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Region (2020-2025)
 Table 19. Global Microneedles for Trans & Intradermal Drug Delivery Sales by Region (2026-2031) & (K Units)
 Table 20. Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Region (2026-2031)
 Table 21. Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Region (2020-2025)
 Table 23. Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Region (2026-2031)
 Table 25. North America Microneedles for Trans & Intradermal Drug Delivery Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2020-2025) & (K Units)
 Table 27. North America Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2026-2031) & (K Units)
 Table 28. North America Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Microneedles for Trans & Intradermal Drug Delivery Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Microneedles for Trans & Intradermal Drug Delivery Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Microneedles for Trans & Intradermal Drug Delivery Sales (K Units) by Type (2020-2025)
 Table 51. Global Microneedles for Trans & Intradermal Drug Delivery Sales (K Units) by Type (2026-2031)
 Table 52. Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Type (2020-2025)
 Table 53. Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Type (2026-2031)
 Table 54. Global Microneedles for Trans & Intradermal Drug Delivery Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Microneedles for Trans & Intradermal Drug Delivery Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Type (2020-2025)
 Table 57. Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Type (2026-2031)
 Table 58. Global Microneedles for Trans & Intradermal Drug Delivery Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Microneedles for Trans & Intradermal Drug Delivery Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Microneedles for Trans & Intradermal Drug Delivery Sales (K Units) by Application (2020-2025)
 Table 61. Global Microneedles for Trans & Intradermal Drug Delivery Sales (K Units) by Application (2026-2031)
 Table 62. Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Application (2020-2025)
 Table 63. Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Application (2026-2031)
 Table 64. Global Microneedles for Trans & Intradermal Drug Delivery Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Microneedles for Trans & Intradermal Drug Delivery Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Application (2020-2025)
 Table 67. Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Application (2026-2031)
 Table 68. Global Microneedles for Trans & Intradermal Drug Delivery Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Microneedles for Trans & Intradermal Drug Delivery Price (USD/Unit) by Application (2026-2031)
 Table 70. Becton Dickinson Company Information
 Table 71. Becton Dickinson Description and Business Overview
 Table 72. Becton Dickinson Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Becton Dickinson Microneedles for Trans & Intradermal Drug Delivery Product
 Table 74. Becton Dickinson Recent Developments/Updates
 Table 75. Nanopass Technologies Company Information
 Table 76. Nanopass Technologies Description and Business Overview
 Table 77. Nanopass Technologies Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Nanopass Technologies Microneedles for Trans & Intradermal Drug Delivery Product
 Table 79. Nanopass Technologies Recent Developments/Updates
 Table 80. Radius Health Company Information
 Table 81. Radius Health Description and Business Overview
 Table 82. Radius Health Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Radius Health Microneedles for Trans & Intradermal Drug Delivery Product
 Table 84. Radius Health Recent Developments/Updates
 Table 85. Clearside Biomedical Company Information
 Table 86. Clearside Biomedical Description and Business Overview
 Table 87. Clearside Biomedical Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Clearside Biomedical Microneedles for Trans & Intradermal Drug Delivery Product
 Table 89. Clearside Biomedical Recent Developments/Updates
 Table 90. Dr. Prausnitz Group Company Information
 Table 91. Dr. Prausnitz Group Description and Business Overview
 Table 92. Dr. Prausnitz Group Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Dr. Prausnitz Group Microneedles for Trans & Intradermal Drug Delivery Product
 Table 94. Dr. Prausnitz Group Recent Developments/Updates
 Table 95. Zosano Pharma Company Information
 Table 96. Zosano Pharma Description and Business Overview
 Table 97. Zosano Pharma Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Zosano Pharma Microneedles for Trans & Intradermal Drug Delivery Product
 Table 99. Zosano Pharma Recent Developments/Updates
 Table 100. Corium International Company Information
 Table 101. Corium International Description and Business Overview
 Table 102. Corium International Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Corium International Microneedles for Trans & Intradermal Drug Delivery Product
 Table 104. Corium International Recent Developments/Updates
 Table 105. Circassia Company Information
 Table 106. Circassia Description and Business Overview
 Table 107. Circassia Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Circassia Microneedles for Trans & Intradermal Drug Delivery Product
 Table 109. Circassia Recent Developments/Updates
 Table 110. Valeritas, Inc. Company Information
 Table 111. Valeritas, Inc. Description and Business Overview
 Table 112. Valeritas, Inc. Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Valeritas, Inc. Microneedles for Trans & Intradermal Drug Delivery Product
 Table 114. Valeritas, Inc. Recent Developments/Updates
 Table 115. BD Medical Company Information
 Table 116. BD Medical Description and Business Overview
 Table 117. BD Medical Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. BD Medical Microneedles for Trans & Intradermal Drug Delivery Product
 Table 119. BD Medical Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Microneedles for Trans & Intradermal Drug Delivery Distributors List
 Table 123. Microneedles for Trans & Intradermal Drug Delivery Customers List
 Table 124. Microneedles for Trans & Intradermal Drug Delivery Market Trends
 Table 125. Microneedles for Trans & Intradermal Drug Delivery Market Drivers
 Table 126. Microneedles for Trans & Intradermal Drug Delivery Market Challenges
 Table 127. Microneedles for Trans & Intradermal Drug Delivery Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Microneedles for Trans & Intradermal Drug Delivery
 Figure 2. Global Microneedles for Trans & Intradermal Drug Delivery Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Microneedles for Trans & Intradermal Drug Delivery Market Share by Type: 2024 & 2031
 Figure 4. Solid Microneedles Product Picture
 Figure 5. Hollow Microneedles Product Picture
 Figure 6. Dissolvable Microneedles Product Picture
 Figure 7. Global Microneedles for Trans & Intradermal Drug Delivery Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Microneedles for Trans & Intradermal Drug Delivery Market Share by Application: 2024 & 2031
 Figure 9. Drugs
 Figure 10. Vaccines
 Figure 11. Proteins
 Figure 12. Peptides
 Figure 13. Others
 Figure 14. Global Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Microneedles for Trans & Intradermal Drug Delivery Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Microneedles for Trans & Intradermal Drug Delivery Sales (2020-2031) & (K Units)
 Figure 17. Global Microneedles for Trans & Intradermal Drug Delivery Average Price (USD/Unit) & (2020-2031)
 Figure 18. Microneedles for Trans & Intradermal Drug Delivery Report Years Considered
 Figure 19. Microneedles for Trans & Intradermal Drug Delivery Sales Share by Manufacturers in 2024
 Figure 20. Global Microneedles for Trans & Intradermal Drug Delivery Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Microneedles for Trans & Intradermal Drug Delivery Players: Market Share by Revenue in Microneedles for Trans & Intradermal Drug Delivery in 2024
 Figure 22. Microneedles for Trans & Intradermal Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Microneedles for Trans & Intradermal Drug Delivery Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Country (2020-2031)
 Figure 25. North America Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Country (2020-2031)
 Figure 26. U.S. Microneedles for Trans & Intradermal Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Microneedles for Trans & Intradermal Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Country (2020-2031)
 Figure 29. Europe Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Microneedles for Trans & Intradermal Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Microneedles for Trans & Intradermal Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Microneedles for Trans & Intradermal Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Microneedles for Trans & Intradermal Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Microneedles for Trans & Intradermal Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Region (2020-2031)
 Figure 37. China Microneedles for Trans & Intradermal Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Microneedles for Trans & Intradermal Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Microneedles for Trans & Intradermal Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Microneedles for Trans & Intradermal Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Microneedles for Trans & Intradermal Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Taiwan Microneedles for Trans & Intradermal Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia Microneedles for Trans & Intradermal Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand Microneedles for Trans & Intradermal Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia Microneedles for Trans & Intradermal Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Philippines Microneedles for Trans & Intradermal Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico Microneedles for Trans & Intradermal Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil Microneedles for Trans & Intradermal Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina Microneedles for Trans & Intradermal Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Microneedles for Trans & Intradermal Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Microneedles for Trans & Intradermal Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. U.A.E Microneedles for Trans & Intradermal Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Microneedles for Trans & Intradermal Drug Delivery by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Microneedles for Trans & Intradermal Drug Delivery by Type (2020-2031)
 Figure 59. Global Microneedles for Trans & Intradermal Drug Delivery Price (USD/Unit) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Microneedles for Trans & Intradermal Drug Delivery by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Microneedles for Trans & Intradermal Drug Delivery by Application (2020-2031)
 Figure 62. Global Microneedles for Trans & Intradermal Drug Delivery Price (USD/Unit) by Application (2020-2031)
 Figure 63. Microneedles for Trans & Intradermal Drug Delivery Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

RELATED REPORTS

Global Surgical Waste Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16G6108
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global PET-CT Scanning Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27Q5892
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Micromanipulation Pipettes for IVF Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14K19926
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Nebulizer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15N17310
Fri Sep 12 00:00:00 UTC 2025

Add to Cart